Education
About Us
Working with TipRanks
Follow Us
NeoGenomics (NEO)
NASDAQ:NEO
Total Valuation
NeoGenomics has a market cap or net worth of $1.15B. The enterprise value is $2.31B.
Market Cap$1.15B
Enterprise Value$2.31B
Share Statistics
NeoGenomics has 128.66M shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding128.66M
Owened by Insiders1.05%
Owened by Instutions23.47%
Financial Efficiency
NeoGenomics’s return on equity (ROE) is -0.09 and return on invested capital (ROIC) is -6.87%.
Return on Equity (ROE)-8.72%
Return on Assets (ROA)-4.81%
Return on Invested Capital (ROIC)-6.87%
Return on Capital Employed (ROCE)-6.89%
Revenue Per Employee$300,257.273
Profits Per Employee-$35,784.545
Employee Count2,200
Asset Turnover0.40
Inventory Turnover13.85
Valuation Ratios
The current PE Ratio of NeoGenomics is -26.51. NeoGenomics’s PEG ratio is 2.32.
PE Ratio-26.51
PS Ratio3.16
PB Ratio2.31
Price to Fair Value2.31
Price to FCF-61.32
Price to Operating Cash Flow297.21
PEG Ratio2.32
Income Statement
In the last 12 months, NeoGenomics had revenue of $660.57M and earned -$78.73M in profits. Earnings per share was -$0.62.
Revenue$660.57M
Gross Profit$283.20M
Operating Income-$88.16M
Pretax Income-$79.87M
Net Income-$78.73M
EBITDA-1.51M
Earnings Per Share (EPS)-0.62
Cash Flow
In the last 12 months, operating cash flow was $7.02M and capital expenditures -$41.06M, giving a free cash flow of -$34.04M billion.
Operating Cash Flow$7.02M
Free Cash Flow-$34.04M
Free Cash Flow per Share-$0.26
Dividends & Yields
NeoGenomics pays an annual dividend of , resulting in a dividend yield of
Dividend Per Share
Dividend Yield
Payout Ratio
Free Cash Flow Yield-1.63%
Earnings Yield-3.77%
Stock Price Statistics
Beta1.32
52-Week Price Change-32.22%
50-Day Moving Average10.80
200-Day Moving Average14.33
Relative Strength Index (RSI)38.97
Average Volume (3m)1.67M
Important Dates
NeoGenomics upcoming earnings date is Apr 29, 2025, TBA.
Last Earnings DateFeb 18, 2025
Next Earnings DateApr 29, 2025
Ex-Dividend Date―
Financial Position
NeoGenomics as a current ratio of 1.98, with Debt / Equity ratio of 0.67
Current Ratio1.98
Quick Ratio1.89
Debt to Market Cap0.29
Net Debt to EBITDA-157.72
Interest Coverage Ratio-13.92
Taxes
In the past 12 months, NeoGenomics has paid -$1.15M in taxes.
Income Tax-$1.15M
Effective Tax Rate0.00%
Enterprise Valuation
NeoGenomics EV to EBITDA ratio is -1.54K, with an EV/FCF ratio of -68.32.
EV to Sales3.52
EV to EBITDA-1.54K
EV to Free Cash Flow-68.32
EV to Operating Cash Flow331.15
Balance Sheet
NeoGenomics has $386.84M in cash and marketable securities with $605.33M in debt, giving a net cash position of $218.49M billion.
Cash & Marketable Securities$386.84M
Total Debt$605.33M
Net Cash$218.49M
Net Cash Per Share$1.70
Tangible Book Value Per Share$0.31
Margins
Gross margin is 43.92%, with operating margin of -13.94%, and net profit margin of -11.92%.
Gross Margin43.92%
Operating Margin-13.94%
Pretax Margin-11.92%
Net Profit Margin-11.92%
EBITDA Margin-0.23%
EBIT Margin-11.21%
Analyst Forecast
The average price target for NeoGenomics is $17.78, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$17.78
Price Target Upside90.77%
Analyst ConsensusModerate Buy
Analyst Count14
Revenue Growth Forecast11.65%
EPS Growth Forecast11.33%